David Dreyer Appointed to Diplomat Board of Directors
FLINT, Mich.— Sept. 19, 2014 — Diplomat, a nationally recognized specialty pharmacy, has announced the appointment of David Dreyer to the Board of Directors on September 15, 2014. Mr. Dreyer is an independent director and will also serve as chair of the Audit Committee.
Mr. Dreyer has almost 30 years of accounting, financial, compliance and operating experience in the health care field. Since October 2010, Mr. Dreyer has served as chief financial officer, chief operating officer and secretary of Patient Safety Technologies, which develops, markets and sells a medical device system that increases patient safety and reduces costs by preventing retained sponges from occurring during surgeries. Patient Safety Technologies is a former public reporting company and, since March 2014, is a subsidiary of Stryker Corporation.
Previously, Mr. Dreyer was chief financial officer of Alphastaff Group Inc., a human resource outsourcing company, from August 2009 to September 2010. From September 2004 to August 2009, Mr. Dreyer served as chief financial officer and chief accounting officer of AMN Healthcare Services Inc., which provided healthcare staffing for physicians, travel nurses and allied travel. From 1997 through 2004, Mr. Dreyer served as chief financial officer and chief accounting officer of Sicor Inc., a manufacturer of complex pharmaceuticals with operations in the United States and internationally, which was acquired by Teva Pharmaceutical Industries Limited in January 2004.
Prior to joining Sicor, Mr. Dreyer served in related senior financial management positions within the pharmaceutical industry, working for Elan Corporation PLC, Athena Neurosciences and Syntex Corporation. Mr. Dreyer has been a director of InfuSystem Holdings Inc., a provider of infusion pumps and related services, since April 2008, and currently serves as a member of the Compensation and Audit Committees and is the chair of the Nominating and Governance Committee. Mr. Dreyer is licensed as a certified public accountant in the state of California.
“We are honored that David Dreyer has joined Diplomat’s Board of Directors,” said Phil Hagerman, co-founder and CEO of Diplomat. “David’s authority on healthcare financial matters and vast experience will be a strong support for Diplomat. He’s a tremendous addition to our Board and I look forward to working with him.”
To learn more, visit diplomat.is.
Diplomat serves patients and physicians in all 50 states as a nationally recognized specialty pharmacy. Headquartered in Flint, Michigan, the company focuses on medication management programs for people with complex chronic diseases, including oncology, immunology, hepatitis, multiple sclerosis, HIV, specialized infusion therapy and many other serious or long-term conditions. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients, and the rest falls into place.” Today, that tradition continues – always focused on improving patient care and clinical adherence. For more information visit www.diplomat.is. Follow us on Twitter and LinkedIn and like us on Facebook.
Jennifer Cretu, Vice President of Marketing + Public Relations, Diplomat
810.768.9370 | email@example.com
@PharmacDailyRT @PharmacDaily: @DiplomatRx to distribute Puma Biotechnology’s new cancer drug $DPLO https://t.co/gl0v6WURVV5 days ago
@DiplomatRxNerlynx (neratinib) tablets for HER2+ Breast Cancer in the Extended Adjuvant Setting https://t.co/vi3ACWhbfe5 days ago
@AJPB_JournalRT @AJPB_Journal: Be sure to check out our Insights page featuring videos of Cheryl Allen from @DiplomatRx discussing #RA https://t.co/qxZc…2 weeks ago
@DiplomatRxWe're with @340BCoalition this week in Washington D.C.! Come say hello.3 weeks ago
@SpecialtyPTimesRT @SpecialtyPTimes: Rheumatoid Arthritis Treatment Guidelines https://t.co/sEhe74UozC #rheumatoidarthritis @DiplomatRx3 weeks ago